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Original Article
Abstract
Background and aims: Postoperative pain control decreases negative effects on the health domains of the patients and their relatives 
in addition to reducing the costs and the duration of hospitalization. The aim of the present study was to comparatively investigate the 
analgesic effects of ginger and diclofenac tablets.
Materials and Methods: In this clinical trial, 80 patients undergoing inguinal hernia surgery were randomly divided into two groups of 
40. One group received 250 mg ginger capsule while the other one received 100 mg diclofenac tablet. Then, the patients were examined 
within 6 hours (every two hours) and their pain was assessed using the standard 10-point visual analogue scale. Finally, the data were 
analyzed using the SPSS, version 22.
Results: Based on the results, there was no significant difference in pain severity between the two groups at 0, 2, 4, and 6 hours after 
recovery (P > 0.05). In addition, no significant difference was observed in the duration of pain since the time of patient recovery between 
the two groups (P > 0.05). Further, as regards the number of patients receiving pethidine, no difference was found between the two groups 
(P > 0.05).
Conclusion: In general, both ginger capsule and diclofenac tablet were similarly effective in relieving the pain after inguinal hernia surgery.
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Introduction 
Pain is one of the major public health issues around 
the world that imposes heavy economic burden on the 
community (1-4). In addition to bothering the patient, 
pain can impair the quality of life and thus adversely affect 
the family and social aspects of the patients’ lives (5). 
Therefore, pain relief in patients reduces the adverse effects 
of pain on the patient’s physical and mental conditions 
and provides comfort for his/her family (6). Postoperative 
pain relief, especially through certain regimens, can 
decrease mortality during and after the operation (7,8). 
Pain control with the least possible complications, as one 
of the dimensions of patient satisfaction with health care 
services, is one of the goals of pain management (6). There 
are several ways to reduce pain in patients. For example, 
nonsteroidal anti-inflammatory drugs and opioids can be 
used to treat various pains, including surgical pain (9). 
Meanwhile, herbal remedies have drawn attention 
because of their cost-effectiveness and fewer side effects 
in long-term use, including chronic pains (10-14). Plants 
can even be used as food supplements and be effective 
in reducing the pain by inducing anti-inflammatory 
properties (15-18). Zingiber officinale rhizome is one of 
the oldest medicinal and preventive remedies for many 
conditions, including pain (19-23). However, despite the 
anti-inflammatory effects of ginger, its effect on pain relief 
is controversial (24). Therefore, the present study was 
conducted to compare the effects of the ginger capsule and 
diclofenac tablet on the relief of pain following inguinal 
hernia surgery.
Materials and Methods
In this prospective double-blind clinical trial, a total of 
80 patients submitted to inguinal hernia repair surgery 
in Kashani hospital of Shahrekord were selected by 
convenience sampling technique. The sample size was 
calculated at 40 for each group using a sample size statistics 
formula and according to the protocol of a similar study 
(25). The inclusion criteria were those patients aged over 
14 years who were eligible for inguinal hernia repair 
surgery and provided consent to participate in the study. 
In addition, the exclusion criteria included over 1-hour 
duration of surgery, classified as higher than ASA (American 
Association of Analgesia) II, a history of cardiovascular, 
liver, kidney, pulmonary, as well as psychiatric diseases, 
epilepsy, and diseases affecting the function of the nervous 
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and muscular system, addicted or alcoholic or the habitual 
use of any related drug, emergency surgery, gastrointestinal 
problems, the unintentional division of ilioinguinal nerve 
and/or iliohypogastric nerve during the surgery, receiving 
analgesics 24 hours before surgery, asthma, eczema or 
hypersensitivity to ginger, recurrent hernia, neurological 
lesions such as stroke, nerve division due to trauma and 
congenital neurological diseases, and the lack of ability 
to communicate verbally and express the pain. The data 
collection instrument was a checklist, the first section of 
which consisted of demographic characteristics such as 
age, a history of underlying diseases, hospitalization and 
surgery records, associated symptoms including nausea 
and vomiting, as well as postoperative complications 
(up to 10 days) including infection and hematoma after 
taking the studied drugs. The second section addressed 
pain severity and the duration of postoperative pain that 
was measured by a standard 10-point visual analogue 
scale (26). Anesthesia was recorded on a 10-point (1-10) 
scale, with the same visual analogue scale form used at all 
intervals, and therefore the patient would select the choice 
that indicated the severity of his/her pain. Before entering 
the operating room, patients received no pretreatment and 
were divided into two groups.
In order to control postoperative pain, the patients in 
the ginger group received one ginger capsule (Zintoma) 
orally with 50 mL water one hour before surgery, while 
the diclofenac group received diclofenac 100 mg with 50 
mL water. Further, both groups received 2 mg midazolam 
one hour before the surgery. In recovery, pulse oximetry 
was monitored and oxygen was given via the facial mask. 
The first examination of the pain was conducted within 
6 hours (once every two hours) after complete recovery 
in the recovery room and after the patient was transferred 
to the department. Furthermore, the pain severity was 
assessed by the visual analogue scale criteria while the 
incidence of vomiting, respiratory depression, urinary 
retention, shivering, and hemodynamic changes, as well as 
the amount and type of injectable drug were monitored by 
a contributor to the research project who was blind to the 
type of the drug prescribed for the patient. The duration 
of the pain for all patients was considered to begin from 
the time the patient recovered to when the pain severity 
decreased to less than three.
In addition, 25 mg of pethidine was injected to the 
patient if requested or needed (pain score higher than 5) 
and the number of injections of pethidine was recorded. 
The obtained data were analyzed by SPSS, version 
22. The frequency and relative frequency were used for 
qualitative variables and mean (standard deviation) was 
employed for quantitative variables. Moreover, qualitative 
variables were analyzed by chi-squared and Fisher exact 
tests and the mean values in the two groups were compared 
by using Student’s t test or its nonparametric equivalent 
(Mann-Whitney test) depending on data distribution. 
P<0.05 was considered statistically significant.
Results
The mean age of the participants in the ginger and 
diclofenac groups was 41.47±14.44 and 44.22±13.22, 
respectively, with no statistically significant difference 
(P < 0.05). Additionally, the age range in all participants was 
16-71 years and 41.7750±14.3574 and 44.025±13.3002 
years in the ginger and diclofenac groups, respectively. The 
results of this study showed that there was no significant 
difference regarding the diseases between the two groups 
(P > 0.05). It was not possible to investigate this issue 
because no side effects such as infection, vomiting, and 
the like were observed in the patients.
Table 1 demonstrates the results related to pain severity 
among the groups receiving ginger and diclofenac. 
Based on the results, no significant difference was found 
regarding pain severity between the two groups at 0, 2, 4, 
and 6 hours after the recovery (P > 0.05).
In addition, the results revealed no significant difference 
in the duration between recovery and pain improvement 
between the two groups (P > 0.05).
The duration of pain in the two groups is shown in 
Table 2. Although there was no significant difference 
between the two groups, most patients experienced pain 
for 3 hours.
Twenty-five milligrams of pethidine was injected to the 
patient with a score of higher than 5 or on his/her own 
request. Accordingly, about 0.12 and 0.1 of the patients 
in the ginger and diclofenac groups, respectively, received 
pethidine on their own request or because of the pain 
score above 5, with no statistically significant difference 
(P > 0.05).
Discussion
This study aimed at comparing the effects of ginger 
capsule and diclofenac tablet on pain relief after inguinal 
hernia surgery. The severity of pain was not significantly 
different between the two groups at different intervals after 
Table 1. Pain severity in the groups receiving ginger capsule and 
diclofenac tablet at different intervals
Time of study
Group
 P value
Ginger capsule Diclofenac
Recovery 5.02±1.44 4.82±1.33 0.552
2 h after recovery 3.17±1.12 3.05±1.03 0.608
4 h after recovery 1.52±1.10 1.4±1.03 0.603
6 h after recovery 0.27±0.84 0.25±0.77 0.893
Table 2. Duration of the pain in the groups receiving ginger capsule 
and diclofenac tablet 
Group
 P value
Ginger capsule Diclofenac
Duration of pain (h) 5.75±1.12 5.70±1.15 0.845
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the recovery. Further, the pain between the recovery and 
pain improvement failed to significantly differ between 
the two groups. Consistent with these results, the positive 
effects of ginger or its derivatives on various types of pains 
were confirmed by other studies, including those of Yip et 
al on knee pain (27), Chen et al on dysmenorrhea (28), 
Black et al on muscle pain (29), Al-Nahain et al on pain 
caused by rheumatoid arthritis (30), and Leach et al on 
osteoarthritis (31). 
However, a review article reported that despite the 
anti-inflammatory effects of ginger, its effect on pain 
relief remains to be elucidated (24). This can be due to 
the differences in the methodology of other studies. 
Additionally, the type of the mental experience of pain, 
the culture, and the type of pain measurement scale could 
lead to inconsistency in the findings.
Ginger rhizome has been used for many human diseases 
such as gastrointestinal in various parts of the world since 
the ancient times, and its medicinal properties have been 
often attributed to the presence of phenolic compounds, 
along with its antioxidant and anti-inflammatory properties 
(32,33). By containing active ingredients such as gingerol, 
ginger can reduce inflammation and thus relieve the pain 
(34). Anthocyanins are glycoside polyhydroxyl derivatives 
and methoxyl, 2-phenylbenzopyrylium salts, as well as non-
toxic and water-soluble pigments that are widely found 
in nature. The red, blue, purple, amethystine, and black 
colors in many fruits, vegetables, and flowers are due to the 
presence of anthocyanins. These compounds are highly 
potent antioxidants that can suppress the pathways related 
to the pain by inhibiting cyclooxygenase and lipoxygenase. 
There are phenolic compounds and anthocyanins such as 
gingerdion, shoagol, and gingerol in ginger (35). These 
three compounds are strong prostaglandin inhibitors 
that prevent the metabolism of arachidonic acid by 
inhibiting cyclooxygenase and lipoxygenases. In addition, 
these compounds can impede inflammatory pathways 
by inhibiting nitric oxide synthase and thus exert their 
analgesic effects (36,37).
Conclusion
Overall, no significant difference was observed between 
ginger and diclofenac in postoperative pain relief, which 
indicates the acceptable analgesic effect of ginger. Besides, 
considering the dose of ginger in this study, it can be 
concluded that higher doses of ginger can even exhibit a 
greater analgesic effect compared to those of diclofenac 
if they cause no side effects. In this study, there was no 
specific side effect in the group receiving ginger and its 
analgesic effect was similar to that of diclofenac. Therefore, 
it seems that ginger supplementation can be used to relieve 
pain with comparatively fewer side effects.
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